Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brothers Enterprises Holding, often referred to as Zhejiang Brothers Pharmaceutical in its pharmaceutical contexts, is a prominent Chinese manufacturer specializing in vitamins, pharmaceutical intermediates, and fine chemicals. The company is one of the world's largest producers of Vitamin K3 and a significant global supplier of Vitamin B1, Vitamin B3 (Niacin/Nicotinamide), and Vitamin B5. Beyond nutrition, the company operates in the pharmaceutical sector by producing active pharmaceutical ingredients (APIs) and intermediates, as well as leather chemicals and wood protection products. Headquartered in Haining, Zhejiang, the company is vertically integrated, maintaining large-scale manufacturing facilities that adhere to international quality standards such as GMP and ISO.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Brothers Pharmaceutical.